Krvácivé stavy
- MUDr. Petr Smejkal, Oddělení klinické hematologie FN Brno, Brno
- MUDr. Jan Blatný, Oddělení klinické hematologie FN Brno, Brno
A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A
Otevřít | 2010 | MUDr. Štěpán Hrabovský
Safety of Recombinant Activated Factor VII in Randomized Clinical Trials
Otevřít | 2010 | MUDr. Zuzana Šustková
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Otevřít | 2009 | MUDr. František Folber
Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors (a multi-centre, randomised, double-blind, cross-over trial)
spojeno s:
A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors
Otevřít | 2008 | MUDr. Petr Smejkal
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors´ Organisation
Otevřít | 2007 | MUDr. Petr Smejkal